Cathie Wood, the founder of ARK Invest, has recently made some notable trades in the stock market. She has bought shares of Tesla and Teradyne, while also adding Crispr stock to her portfolio.
Wood’s decision to invest in Tesla is not surprising, as the electric vehicle company has been a favorite among ARK Invest’s funds. Tesla’s innovative technology and strong growth potential make it an attractive choice for long-term investors like Wood.
Teradyne, a semiconductor testing company, is another stock that Wood has added to her portfolio. With the increasing demand for semiconductors in various industries, Teradyne’s products and services are likely to see continued growth in the future.
In addition to Tesla and Teradyne, Wood has also purchased shares of Crispr, a company that specializes in gene editing technology. This move reflects Wood’s interest in disruptive technologies that have the potential to revolutionize industries and improve human health.
Overall, Cathie Wood’s recent trades indicate her confidence in the long-term growth prospects of these companies. Investors who follow Wood’s strategies may find her stock picks to be worth considering for their own portfolios.